Bringing the joy of sight across borders to the world!
We've launched our 11th year of "Domestic and International Eye Care Support Activities" with 10 business partners
. As a "Social Partner," we'll use a portion of our eye drop sales to support a wide range of activities, from ophthalmic medical care to everyday eye care awareness campaigns.
November 18, 2026
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, President: Hidetoshi Segi) will, as part of its activities to support the "joy of seeing" for people around the world, donate a portion of its sales to support ophthalmic medical care, such as cataract treatment, in Asia, Africa, and other regions, in collaboration with 10 business partners. For this 11th term, a portion of sales from November 1, 2026 to March 31, 2027 will be donated to organizations that support ophthalmic medical care, such as cataract treatment, mainly in Asia and Africa, as well as organizations that protect the eyes of children.
Launched in 2016, this initiative is now in its 11th year, and continues to expand into a social contribution activity that supports the "visible joy" of people around the world and the children who will shape Japan's future, through collaboration between companies that transcend traditional boundaries.
Social Partner Business Partners (in alphabetical order)
<11th term: November 1, 2026 - March 31, 2027 (※Some companies may have different terms)>
Akakabe Co., Ltd.,
Iwate Consumers' Cooperative,
Kyorindo Pharmacy Co.,
Ltd., Kusuri no Sunroad
Co., Ltd.,
Kokumin Co., Ltd., Sapporo Drugstore Co., Ltd.
, Tomod
's Co., Ltd., Miyagi Consumers' Cooperative, Yakuodo Co., Ltd.,
Yamazawa Pharmaceutical Co.
, Ltd.
What is a social partner?
This retail business partner works in conjunction with Rohto Pharmaceutical Co., Ltd. to donate a portion of its sales to social contribution activities, such as medical support in Japan and around the world. For the 11th term, a portion of the sales of "V ROHTO PREMIUM," "V Rohto Contact Premium," "V Rohto Active Premium," "V Rohto Dry Guard Premium," and "Rohto Kodomo Soft" from November 1, 2026 to March 31, 2027 will be donated.
From left to right: "V ROHTO PREMIUM" (Category 2 pharmaceutical): for tired and red eyes; "V Rohto Contact Premium" (Category 3 pharmaceutical): for discomfort while wearing contact lenses; "V Rohto Active Premium" (Category 2 pharmaceutical): for tired eyes and blurred vision due to excessive eye discharge; "V Rohto Dry Guard Premium" (Category 3 pharmaceutical): for dry eyes; "Rohto Kodomo Soft" (Category 3 pharmaceutical): for eye strain in children.
- "V ROHTO PREMIUM" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "Contact Premium" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "V Rohto Active Premium" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "Dryguard Premium" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
- "Kodomo Soft" is a registered trademark of ROHTO Pharmaceutical Co., Ltd.
Total amount of donations to date
From the first to the tenth phase, we received support from 38 of our business partners, and the total amount of donations reached 18,741,850 yen.
Background of the activities
Cataracts are the leading cause of blindness worldwide, and it is estimated that tens of millions of people still lose their sight each year. Cataracts are a disease in which the lens of the eye, which acts as the eye's lens, becomes cloudy, leading to decreased vision. In Japan, advances in surgical techniques have significantly reduced blindness due to cataracts, but in developing countries, poverty, a shortage of doctors and medical equipment, and underdeveloped surgical systems mean that many people still cannot receive treatment. Our company has been working to provide free eye examinations, intraocular lenses, and train local doctors, but our support has not been sufficient. With the desire to bring the "joy of seeing" to more people, we have been collaborating with our business partners as "social partners" to expand the circle of support.
Furthermore, in recent years, childhood myopia has been rapidly increasing in Japan, making the importance of daily eye care awareness even greater. Our company is strengthening awareness activities and product development to protect children's eyes, and from our 10th term onwards, we will add "Rohto Kodomo Soft" to our target product line and work even harder with our social partners to support activities that protect children's eyes.
Donation recipient
We plan to donate to organizations, medical institutions, and groups that protect children's eyes, providing support for treating cataracts that can cause blindness in Asia, Africa, and other regions, as well as offering ophthalmic medical equipment and intraocular lens medications.
Results of the 10th Phase of Support Activities
OUI Inc. (OUI Corporation)
OUI Inc. is a venture company spun off from Keio University School of Medicine, founded by a practicing ophthalmologist. Their mission is to reduce blindness worldwide by 50% and protect people's health through eye care.
Based on the concept of spreading the "eyes" of ophthalmologists to the world, they have developed a smartphone-attachable ophthalmic diagnostic device called Smart Eye Camera (SEC). Using the portable and easy-to-use SEC, they are dedicated to delivering ophthalmic medical care to patients around the world, including those in developing countries, who have previously had difficulty accessing ophthalmic medical care itself.
NPO Asia Blindness Prevention Association
The NPO Asia Blindness Prevention Association was founded by a group of volunteers who sympathized with Dr. Tadashi Hattori, a graduate of the Department of Ophthalmology at Kyoto Prefectural University of Medicine. With the desire to prevent even one person from losing their sight in the Indochina Peninsula and other poor countries in Asia, mainly Vietnam, the organization provides free ophthalmic treatment and technical training in those areas.
Reference Information: Our company's social contribution activities related to eye health overseas
Supporting the Amazon Cataract Eradication Project
This initiative has been providing continuous support for over 20 years to improve the situation of indigenous communities in Brazil who have difficulty accessing ophthalmic care. Our Brazilian eye drop manufacturer and distributor, Ophthalmos S.A., participates as volunteer staff and provides cataract surgery products free of charge, contributing to healthcare that transcends regional and ethnic barriers.
PT. Rohto Laboratories Indonesia 's support for free cataract surgeries
PT. Rohto Laboratories Indonesia in the ASEAN region to manufacture and sell intraocular lenses for cataract surgery. For many years, the company has been engaged in social contribution activities, including providing intraocular lenses free of charge, in close cooperation with various stakeholders such as hospitals, ophthalmology clinics, and foundations. These activities extend beyond Indonesia to neighboring countries, including Thailand and Myanmar, contributing to the overall "eye health" of the region.
Bringing the joy of seeing to the world, beyond national borders! The "Joy of Seeing Project"
In collaboration with the Rohto Group overseas, we are continuously developing the "Joy of Seeing (JoS)" project both domestically and internationally to protect people's eye health worldwide. By 2025, in addition to addressing "children's eye health and myopia," we expanded our activities to 13 countries and regions, mainly in Asia, including Japan, to address issues such as cataracts and dry eye. We have collaborated with local stakeholders to carry out social contribution activities such as awareness events (with a total of approximately 85,300 participants), free eye examinations (over 65,300 people), information dissemination, and the free provision of eyeglasses and other related items. Through these efforts, we are contributing to the realization of a sustainable society and the improvement of the health of local communities.
Details of the initiative, 2025 activity report